In 1994, researchers discovered a related orphan receptor with high homology to REV-ERBα, named NR1D2 or REV-ERBβ REV-ERBα/β proteins (12), essential components of the circadian clock, are widely expressed across tissues and have become key therapeutic targets for heart diseases (13). The gene discussed is CLOCK; the disease is heart disorder.